Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Pulmonary inflammation caused by chitosan microparticles.

Y C Huang1, A Vieira, K L Huang

  • 1Graduate Institute of Life Science, National Defense Medical Center, University of National Defense, Taipei, Taiwan. yuh@sfu.ca

Journal of Biomedical Materials Research. Part A
|August 2, 2005
PubMed
Summary

Inhaled chitosan microparticles (CM) cause mild, dose-dependent inflammation in rat lungs, evidenced by increased inflammatory markers. These effects are less severe than lipopolysaccharide (LPS) but warrant consideration for pulmonary drug delivery.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Cross-sectional survey of resistant priority pathogen carriage in the hospital setting in Timor-Leste 2020-2021.

Antimicrobial resistance and infection control·2026
Same author

[Identification of advanced heart failure and timing of intervention].

Zhonghua xin xue guan bing za zhi·2025
Same author

[The multi-center mid-term clinical outcomes of combined complete preservation of chordal structure mitral valve replacement with total anatomic complete arterial myocardial revascularization for coronary patients with moderate-to-severe or severe ischemic mitral regurgitation].

Zhonghua wai ke za zhi [Chinese journal of surgery]·2024
Same author

Serum Neutrophil Biomarkers to Predict Crohn's Disease Progression and Infliximab Treatment Outcomes.

United European gastroenterology journal·2024
Same author

TB programme outcomes in South Fly District, Papua New Guinea, were maintained through COVID-19.

Public health action·2024
Same author

Continuous quality improvement in a community-wide TB screening and prevention programme in Papua New Guinea.

Public health action·2024

Area of Science:

  • Biomaterials Science
  • Pulmonary Pharmacology
  • Toxicology

Background:

  • Chitosan, a chitin-derived biopolymer, shows promise for drug delivery to mucosal surfaces.
  • Inhaled chitosan microparticles (CM) are being explored for pulmonary pharmacotherapy.

Purpose of the Study:

  • To investigate the basic reactions of rat lung tissue to inhaled CM.
  • To quantify the dose-dependent inflammatory effects of CM in the lungs.

Main Methods:

  • Rats were exposed to varying doses of CM (2-10 mg/kg).
  • Bronchoalveolar lavage fluid (BALF) was analyzed for protein (BALF-P) and lactate dehydrogenase (BALF-LDH) activity.
  • Lung tissue was assessed for myeloperoxidase (MPO) activity and leukocyte migration.
  • Cytological examination of BALF identified inflammatory cell infiltration.

Related Experiment Videos

Main Results:

  • Inhaled CM induced dose-dependent increases in BALF-P, BALF-LDH, and MPO activity.
  • Biochemical markers indicated an average 1.8-fold increase in inflammation compared to controls.
  • A sixfold increase in polymorphonuclear neutrophils was observed in BALF after CM inhalation.
  • CM-induced inflammation was 1.9-fold lower than that caused by lipopolysaccharide (LPS).

Conclusions:

  • Inhaled CM elicit significant, yet mild relative to LPS, proinflammatory effects on lung tissue.
  • The observed inflammatory responses necessitate careful consideration for therapeutic applications involving pulmonary delivery of CM at these concentrations.